Merck & Co halted the trial after the advisory committee recommended ending the carotid intima-media thickness study of the niacin/laropiprant combination, two months after the committee urged the enrollment of more patients to be put on hold. Heartwire
Dr. Simon A. Mallal discusses the latest data from CROI 2008 in regard to the metabolic comorbidities associated with HIV infection and antiretroviral therapy. Medscape HIV/AIDS
The lack of superiority of combination therapy vs epinephrine alone suggests it may be futile to add vasopressin to epinephrine during cardiopulmonary resuscitation with advanced cardiac life support. Medscape Medical News
True secondary hypertension represents only about 5% of patients -- in his video blog Dr. Black presents detailed criteria for how clinicians can efficiently assess its possible causes. Medscape Cardiology
Provisional T-stenting using the Taxus stent, instead of the crush or culotte techniques, is associated with a lower rate of death, MI, and target vessel failure at one year, results from the BBC ONE trial show. Heartwire
